Gambro BCT, Inc. manufactures automated blood collection systems. The company offers Trima Accel collection system that collects a combination of leukoreduced red blood cells, and platelets and plasma; Vista information system, which enhances blood center operations by integrating key functions and providing data; and COBE Spectra apheresis system that delivers cell therapy and therapeutic apheresis on one platform. It also offers Elutra Cell separation system that allows cell populations into multiple fractions based on size and density; Atreus whole blood processing system that produces components from blood; and Mirasol pathogen reduction technology, which reduces pathogens found in collected blood, as well as accessories and supplies. In addition, the company supports a range of cellular therapies, as well as therapeutic apheresis procedures for the treatment of cancer, and congenital and immune disorders. It has operations in North America, Latin America, Asia and Pacific, and Europe. Gambro BCT, Inc. is based in Lakewood, Colorado. Gambro BCT, Inc. operates as a subsidiary of Gambro AB.